Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential ATRA and IL-2 in Metastatic Renal Cancer
NCT00100906Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Aug 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin in renal cell carcinoma (RCC), sponsored by Moffitt Cancer Center. Started Aug 2004; status: completed.
02
Drugs
tretinoin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00100906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100906.